NFKB2 and B-cell non-Hodgkin lymphoma: In Eμ-MYC transgenic mice, where MYC overexpression drives B-cell lymphoma, NFκB2 loss accelerates tumor development by impairing MYC-dependent apoptosis, highlighting the tumor suppressor function of the non-canonical NFκB pathway [55].